ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Suramin in Non-small Cell Lung Cancer and Advanced Breast Cancer: Two Parallel Phase II Studies
Acta Oncologica
◽
10.3109/02841869709109226
◽
1997
◽
Vol 36
(2)
◽
pp. 171-174
◽
Cited By ~ 20
Author(s):
Mansoor R. Mirza
◽
Erik Jakobsen
◽
Per Pfeiffer
◽
Bente Lindebjerg-Clasen
◽
Jonas Bergh
◽
...
Keyword(s):
Breast Cancer
◽
Lung Cancer
◽
Small Cell Lung Cancer
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Advanced Breast
◽
Small Cell Lung
◽
Phase Ii Studies
Download Full-text
Related Documents
Cited By
References
Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies
Annals of Oncology
◽
10.1093/annonc/mdx380.050
◽
2017
◽
Vol 28
◽
pp. v482
◽
Cited By ~ 6
Author(s):
T. Mitsudomi
◽
M.-J. Ahn
◽
L. Bazhenova
◽
F. Blackhall
◽
T. Hida
◽
...
Keyword(s):
Lung Cancer
◽
Overall Survival
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Two Phase
◽
Phase Ii Studies
◽
Egfr T790m
Download Full-text
Dose scheduling & drug tolerability in phase II studies of gemcitabine and cisplstin chemotherapy for non-small cell lung cancer
European Journal of Cancer
◽
10.1016/s0959-8049(97)85869-8
◽
1997
◽
Vol 33
◽
pp. S236-S237
◽
Cited By ~ 1
Author(s):
R.P. Abratt
◽
A. Sandler
◽
L. Crino
◽
W. Steward
◽
F. Shepherd
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Drug Tolerability
◽
Phase Ii Studies
Download Full-text
Phase II studies of AZD1775, a WEE1 kinase inhibitor, and chemotherapy in non-small-cell lung cancer (NSCLC): Lead-in cohort results
Annals of Oncology
◽
10.1093/annonc/mdw368.22
◽
2016
◽
Vol 27
◽
pp. vi121
Author(s):
D.R. Spigel
◽
S. Dakhil
◽
J.T. Beck
◽
A. Sadiq
◽
S. Menon
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Kinase Inhibitor
◽
Small Cell
◽
Small Cell Lung
◽
Phase Ii Studies
◽
Wee1 Kinase
Download Full-text
3113 AZD9291 in pre-treated patients with T790M positive advanced non-small cell lung cancer (NSCLC): Pooled analysis from two Phase II studies
European Journal of Cancer
◽
10.1016/s0959-8049(16)31754-3
◽
2015
◽
Vol 51
◽
pp. S640
◽
Cited By ~ 4
Author(s):
G.D. Goss
◽
J.C.H. Yang
◽
M.J. Ahn
◽
C.M. Tsai
◽
L. Bazhenova
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Pooled Analysis
◽
Small Cell
◽
Small Cell Lung
◽
Two Phase
◽
Phase Ii Studies
Download Full-text
Comparison of safety and efficacy between squamous and non-squamous non-small cell lung cancer (NSCLC) patients in phase II studies of DMXAA (ASA404)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.8072
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 8072-8072
◽
Cited By ~ 4
Author(s):
M. J. McKeage
◽
M. B. Jameson
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase Ii Studies
◽
Nsclc Patients
Download Full-text
Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide
Lung Cancer
◽
10.1016/0169-5002(94)94255-2
◽
1994
◽
Vol 11
◽
pp. 126
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Phase Ii Studies
Download Full-text
3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies
European Journal of Cancer
◽
10.1016/s0959-8049(16)31724-5
◽
2015
◽
Vol 51
◽
pp. S625-S626
◽
Cited By ~ 30
Author(s):
M.J. Ahn
◽
C.M. Tsai
◽
J.C.H. Yang
◽
F.A. Shepherd
◽
M. Satouchi
◽
...
Keyword(s):
Lung Cancer
◽
Brain Metastases
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Phase Ii Studies
◽
Egfr Mutant
Download Full-text
P3.02a-016 Pooled Efficacy and Safety Data from Two Phase II Studies (NP28673 and NP28761) of Alectinib in ALK+ Non-Small-Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2016.11.1646
◽
2017
◽
Vol 12
(1)
◽
pp. S1170-S1171
Author(s):
James Chih-Hsin Yang
◽
Sai-Hong Ou
◽
Luigi De Petris
◽
Shirish Gadgeel
◽
Leena Gandhi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Safety Data
◽
Small Cell
◽
Efficacy And Safety
◽
Small Cell Lung
◽
Two Phase
◽
Phase Ii Studies
Download Full-text
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer
Expert Opinion on Investigational Drugs
◽
10.1517/13543784.2015.1056341
◽
2015
◽
Vol 24
(9)
◽
pp. 1143-1161
◽
Cited By ~ 5
Author(s):
Sara Pilotto
◽
Silvia Novello
◽
Umberto Peretti
◽
Stefania Kinspergher
◽
Ludovica Ciuffreda
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Angiogenesis Inhibitors
◽
Small Cell
◽
Small Cell Lung
◽
Phase Ii Studies
Download Full-text
147 Phase II studies of a 60 mg/m2 dose of docetaxel in patients with non-small cell lung cancer
Lung Cancer
◽
10.1016/s0169-5002(97)89426-3
◽
1997
◽
Vol 18
◽
pp. 40
Author(s):
S. Hiraki
◽
K. Watanabe
◽
K. Furuse
◽
S. Kudo
◽
T. Ohnoshi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Phase Ii Studies
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close